A multicenter randomized controlled clinical trial confirms that both chemical-first and electrical-first approaches are effective strategies for acute atrial fibrillation; however, an ...

Recent-onset atrial fibrillation, defined as an onset within one week, is a major issue in clinical practice, and recent advances have shown that cardioversion to normal sinus rhythm provides better ...

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...

A 70-year-old man comes to the clinic for routine follow-up of hypertension and is found to have new atrial fibrillation of unknown duration. Atrial fibrillation increases the risk of mortality and ...

For people hospitalized with ischemic stroke and atrial fibrillation (AFib), restoring the heart's normal rhythm within eight ...

Demonstrating one potential application of the technology, an automated algorithm tied to the KardiaBand wearable ECG (AliveCor) performed “reasonably well” at detecting A-fib in patients scheduled ...

ROME -- Edoxaban (Savaysa) appears at least as safe as the standard warfarin (Coumadin)/enoxaparin (Lovenox) strategy for use in bridging anticoagulation around cardioversion for recent onset atrial ...

Pharmacological- and electrical-first cardioversion worked similarly well for treating acute atrial fibrillation (Afib) in the emergency department, according to the Canadian RAFF2 trial. The 204 ...

Newswise — A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients ...